In addition to increased size, cardiomyocytes from NAP1L1 p.D349E AAV-treated mice showed more severe myocardial fibrosis (Fig. 3F, G and Supplementary Fig. S6C). The gene discussed is NAP1L1; the disease is Myocardial fibrosis.